Sicomed Bucharest, Romania’s largest drugmaker, is after a 15% sales increase (as compared to 2002’s $38m) this year. The company also aims to complete the $3m investment project set to modernise the tablet section and to improve the cash flow, the company’s managers say.”We shall be more aggressive on the Romanian market and will also launch new products. The 15% turnover increase and the bigger profits will also be triggered by a more significant contribution of exports,” Klaas Postema (photo), Sicomed general manager told Ziarul Financiar. ZF



Subiecte #growth#oldid19227#Sicomed#targets